Abstract

As the central effector of visual transduction, the regulation of photoreceptor phosphodiesterase (PDE6) is controlled by both allosteric mechanisms and extrinsic binding partners. However, the conformational changes and interactions of PDE6 with known interacting proteins are poorly understood. Using a fluorescence detection system for the analytical ultracentrifuge, we examined allosteric changes in PDE6 structure and protein-protein interactions with its inhibitory γ-subunit, the prenyl-binding protein (PrBP/δ), and activated transducin. In solution, the PDE6 catalytic dimer (Pαβ) exhibits a more asymmetric shape (axial ratio of 6.6) than reported previously. The inhibitory Pγ subunit behaves as an intrinsically disordered protein in solution but binds with high affinity to the catalytic dimer to reconstitute the holoenzyme without a detectable change in shape. Whereas the closely related PDE5 homodimer undergoes a significant change in its sedimentation properties upon cGMP binding to its regulatory cGMP binding site, no such change was detected upon ligand binding to the PDE6 catalytic dimer. However, when Pαβ was reconstituted with Pγ truncation mutants lacking the C-terminal inhibitory region, cGMP-dependent allosteric changes were observed. PrBP/δ bound to the PDE6 holoenzyme with high affinity (K(D) = 6.2 nm) and induced elongation of the protein complex. Binding of activated transducin to PDE6 holoenzyme resulted in a concentration-dependent increase in the sedimentation coefficient, reflecting a dynamic equilibrium between transducin and PDE6. We conclude that allosteric regulation of PDE6 is more complex than for PDE5 and is dependent on interactions of regions of Pγ with the catalytic dimer.

Highlights

  • Photoreceptor PDE6 is the central enzyme in vision, but conformational changes during visual transduction are not understood

  • Because PDE5 and PDE6 are closely related structurally and biochemically, we examined whether ligandinduced conformational changes could be observed for both the PDE5 and PDE6 enzyme families

  • In contrast to the other GAF-containing phosphodiesterases (PDE2, PDE5, PDE10, and PDE11) in which ligand binding to the GAF domains is allosterically communicated to the enzyme active site to enhance catalysis, there is no biochemical evidence supporting direct allosteric regulation of the PDE6 catalytic dimer (P␣␤) by cGMP binding (14 –16)

Read more

Summary

Background

Photoreceptor PDE6 is the central enzyme in vision, but conformational changes during visual transduction are not understood. Results: Binding of cGMP or regulatory proteins to PDE6 induces conformational changes detected by analytical ultracentrifugation. As the central effector of visual transduction, the regulation of photoreceptor phosphodiesterase (PDE6) is controlled by both allosteric mechanisms and extrinsic binding partners. Using a fluorescence detection system for the analytical ultracentrifuge, we examined allosteric changes in PDE6 structure and protein-protein interactions with its inhibitory ␥-subunit, the prenyl-binding protein (PrBP/␦), and activated transducin. The inhibitory P␥ subunit behaves as an intrinsically disordered protein in solution but binds with high affinity to the catalytic dimer to reconstitute the holoenzyme without a detectable change in shape. The molecular organization of the catalytic subunits have been revealed at low resolution using electron microscopy and image analysis of rod PDE6 (9 –11), very little is known about the conformational changes likely to occur to the P␣␤ catalytic dimer upon binding

The abbreviations used are
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
Summary of sedimentation properties
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call